BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 17195912)

  • 1. Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer.
    Maestro ML; Vidaurreta M; Sanz-Casla MT; Rafael S; Veganzones S; Martínez A; Aguilera C; Herranz MD; Cerdán J; Arroyo M
    Ann Surg Oncol; 2007 Mar; 14(3):1229-36. PubMed ID: 17195912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
    Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
    Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
    Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
    Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel.
    Vilkin A; Niv Y; Nagasaka T; Morgenstern S; Levi Z; Fireman Z; Fuerst F; Goel A; Boland CR
    Cancer; 2009 Feb; 115(4):760-9. PubMed ID: 19127559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.
    Deng G; Bell I; Crawley S; Gum J; Terdiman JP; Allen BA; Truta B; Sleisenger MH; Kim YS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):191-5. PubMed ID: 14734469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors.
    Veganzones S; Maestro ML; Rafael S; de la Orden V; Vidaurreta M; Mediero B; Espantaleón M; Cerdán J; Díaz-Rubio E
    Tumour Biol; 2015 May; 36(5):3853-61. PubMed ID: 25576161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
    Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
    Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of mutator pathway in younger-age-onset colorectal adenocarcinomas.
    Roh SA; Kim HC; Kim JS; Kim JC
    J Korean Med Sci; 2003 Jun; 18(3):387-91. PubMed ID: 12808326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.
    Kumar K; Brim H; Giardiello F; Smoot DT; Nouraie M; Lee EL; Ashktorab H
    Clin Cancer Res; 2009 Feb; 15(4):1155-61. PubMed ID: 19190129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
    Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
    J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter.
    Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL
    Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
    Minoo P; Moyer MP; Jass JR
    J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The profile of hMLH1 methylation and microsatellite instability in colorectal and non-small cell lung cancer.
    Okuda T; Kawakami K; Ishiguro K; Oda M; Omura K; Watanabe G
    Int J Mol Med; 2005 Jan; 15(1):85-90. PubMed ID: 15583832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
    McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
    Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas.
    Strazzullo M; Cossu A; Baldinu P; Colombino M; Satta MP; Tanda F; De Bonis ML; Cerase A; D'Urso M; D'Esposito M; Palmieri G
    Cancer; 2003 Oct; 98(7):1540-6. PubMed ID: 14508843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
    Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
    Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.
    Gafà R; Maestri I; Matteuzzi M; Santini A; Ferretti S; Cavazzini L; Lanza G
    Cancer; 2000 Nov; 89(10):2025-37. PubMed ID: 11066042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer.
    de Vogel S; Bongaerts BW; Wouters KA; Kester AD; Schouten LJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; van Engeland M; Weijenberg MP
    Carcinogenesis; 2008 Sep; 29(9):1765-73. PubMed ID: 18339680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
    Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
    Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.